Welcome to our dedicated page for Mcewen Mng SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing hundreds of pages on ore grades, cash costs, and country-specific mining laws inside McEwen Mining’s SEC documents can drain valuable research time. Whether you need the latest production data from Nevada’s Gold Bar or clarity on reclamation liabilities in Mexico, each disclosure layer in the 10-K or 10-Q adds complexity.
Stock Titan’s AI-powered summaries break down every McEwen Mining SEC filing—annual report 10-K, quarterly earnings report 10-Q, 8-K material events, and the proxy statement executive compensation section—into concise insights. Real-time alerts flag McEwen Mining insider trading Form 4 transactions, so you know when executives adjust their positions. Our platform links drilling results to segment revenue, highlights exploration spending, and interprets reserve revisions, letting you focus on decisions instead of document mining.
Investors typically ask where to find specific details, so we grouped answers by filing type:
- “McEwen Mining quarterly earnings report 10-Q filing” – see production costs, metal sales, and AI commentary on segment margins.
- “McEwen Mining annual report 10-K simplified” – access a plain-English summary of reserve tables, jurisdictional risks, and sustainability disclosures.
- “McEwen Mining Form 4 insider transactions real-time” – monitor executive stock trades as they hit EDGAR.
- “McEwen Mining 8-K material events explained” – understand mine shutdowns, joint ventures, or financing updates in minutes.
From understanding McEwen Mining SEC documents with AI to tracking McEwen Mining earnings report filing analysis, our coverage turns technical mining language into actionable data. Save hours, compare quarter-over-quarter reserve changes, and spot trends faster—without sifting through every appendix.
McEwen Inc. (MUX) reported equity awards to its Chief Financial Officer, Perry Ing, reflecting a compensation grant recorded on 08/11/2025. The grant consists of 50,000 stock options with an exercise price of $10.43 and 5,600 restricted stock units (RSUs). After the reported transactions the reporting person beneficially owns 50,000 option rights and 5,600 RSU rights shown on the form as direct holdings.
The option award vests in three equal annual installments beginning August 11, 2026 and the option has an indicated expiration or last date of 08/11/2030. Each RSU represents a contingent right to one share (or cash at the issuer's discretion) and will vest in three approximately equal installments on December 29, 2025, June 29, 2026 and December 29, 2026. The Form 4 lists these as acquisitions (Transaction Code A) and identifies the awards as direct beneficial ownership.
Alfred Aguilar Colas, identified as a director of McEwen Inc. (MUX), acquired 10,000 stock options on 08/11/2025 with an exercise price of $10.43. The options cover 10,000 shares of common stock, are reported as directly beneficially owned following the transaction, and have an expiration date of 08/11/2030.
The filing states the options vest in three equal annual installments beginning 08/11/2026. The transaction is reported as an acquisition (code "A") and the form indicates it was filed by one reporting person.
Stephen Douglas Kaszas, a director of McEwen Inc. (MUX), was granted a stock option on 08/11/2025 to buy 10,000 shares of common stock at an exercise price of $10.43. The Form 4 reports the option as an acquisition and shows 10,000 derivative securities beneficially owned following the transaction, held directly. The option vests in three equal annual installments beginning August 11, 2026 and the option expires on August 11, 2030. The filing was made by one reporting person and identifies Kaszas relationship to the issuer as a director.
McEwen Inc. insider Robert Ross McEwen, who serves as Chief Executive Officer, a director and a greater-than-10% owner, was granted a stock option that gives him the right to buy 170,000 shares of McEwen Inc. common stock at an exercise price of $10.43 per share. The transaction is dated 08/11/2025 and the option expires on 08/11/2030. The options are documented as a stock option (right to buy) and are held directly by Mr. McEwen.
The grant vests in three equal annual installments beginning on 08/11/2026, which staggers exercisability over three years. Following the reported transaction, Mr. McEwen beneficially owns 170,000 options. The filing discloses standard Section 16 insider compensation activity without additional context on total outstanding shares or aggregate insider holdings in the filing text provided.
Jeffrey Chan, McEwen Inc.'s VP-Finance, reported equity awards dated 08/11/2025: a stock option to purchase 40,000 shares at an exercise price of $10.43 (expiration 08/11/2030) and 3,800 restricted stock units (RSUs). The option vests in three equal annual installments beginning 08/11/2026. The RSUs vest in three approximately equal installments on 12/29/2025, 06/29/2026 and 12/29/2026.
Each RSU represents a contingent right to one share of common stock or the cash value thereof as provided in the award agreement. Both grants are reported as direct beneficial ownership. The filing records compensation-related awards rather than open-market purchases or dispositions.
McEwen Inc. (MUX) director Michelle Makori was granted 20,000 stock options with an exercise price of $10.43 on 08/11/2025. The options are exercisable for common stock, held directly, and the grant leaves the reporting person with 20,000 derivative securities following the transaction.
The options vest in three equal annual installments beginning on August 11, 2026 and carry an expiration date of 08/11/2030. This filing records a standard equity grant to a director: it details the grant size, strike price, vesting schedule and expiration but contains no additional cash sales, purchases or other compensation adjustments.
McEwen Inc. reporting person Ian J. Ball, a director, acquired derivative securities in the form of stock options. The Form 4 shows an acquisition of 20,000 stock options with an exercise price of $10.43. The transaction date recorded is 08/11/2025, and the options vest in three equal annual installments beginning on August 11, 2026. The options have an expiration date listed as 08/11/2030 and are reported as directly owned following the transaction. The filing does not disclose any cash payment amount for the grant beyond the stated exercise price or any change in other holdings.
McEwen Inc. issued a press release on August 7, 2025 summarizing its second quarter and half‑year financial and operating results and providing certain operational updates; that press release is furnished as Exhibit 99.1 to this Form 8-K.
The filing states the information furnished under Item 2.02 is not to be deemed "filed" for purposes of Section 18 and is not incorporated by reference in other Securities Act filings. The document includes a cautionary statement that the press release contains forward‑looking statements about production, costs, exploration, development and financing and refers readers to the company’s 2024 Form 10-K and other filings for risk factors. The report is signed by Carmen Diges, General Counsel, dated August 8, 2025.